<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04755712</url>
  </required_header>
  <id_info>
    <org_study_id>2020-A03334-35</org_study_id>
    <nct_id>NCT04755712</nct_id>
  </id_info>
  <brief_title>Comparison of Two Analgesic Strategies After Scheduled Caesarean</brief_title>
  <official_title>Comparison of Two Analgesic Strategies After Scheduled Caesarean : Block of the Lumbar Region With Ropivacaine Versus Intrathecal Morphine</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>GCS Ramsay Santé pour l'Enseignement et la Recherche</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>GCS Ramsay Santé pour l'Enseignement et la Recherche</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To demonstrate the superiority of square lumbar block to ropivacaine compared to intrathecal&#xD;
      morphine in the efficacy of postoperative analgesia following scheduled caesarean.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Interventional, comparative, randomized, controlled study versus reference therapeutic&#xD;
      strategy, in 2 parallel groups, double-blind (patient and evaluator), single-center, aiming&#xD;
      to demonstrate the superiority of ropivacaine in square lumbar block versus intrathecal&#xD;
      morphine, on the efficacy of post-operative analgesia, following a scheduled caesarean.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 22, 2021</start_date>
  <completion_date type="Anticipated">March 2022</completion_date>
  <primary_completion_date type="Anticipated">March 2022</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Cumulative quantity of morphine received postoperatively via pump</measure>
    <time_frame>2 days</time_frame>
    <description>The main objective of the study is to demonstrate the superiority of square lumbar block to ropivacaine (quadratum lumburum block 2 - QLB2) in comparison to intrathecal morphine in the efficacy of postoperative analgesia following a scheduled Caesarean.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Characteristics of postoperative pain using a visual analogic scale</measure>
    <time_frame>2 days</time_frame>
    <description>Evaluate the characteristics of postoperative pain in both groups with the use of a visual analog scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Side effects of the two analgesic strategies</measure>
    <time_frame>2 days</time_frame>
    <description>Evaluate the side effects of the two analgesic strategies reported in a case report form</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">104</enrollment>
  <condition>Analgesia</condition>
  <arm_group>
    <arm_group_label>ropivacaine in quadratum lumburum block 2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Ropivacaine will be administrated in perineural in quadratum lumburum block 2 after the caesarian.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Intrathecal morphine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Morphine will be administrated in intrathecal</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Rachianesthesia</intervention_name>
    <description>Administration of different anesthesia drugs in accordance with the courant practice (mixture of bupivacaine and sufentanil)</description>
    <arm_group_label>Intrathecal morphine</arm_group_label>
    <arm_group_label>ropivacaine in quadratum lumburum block 2</arm_group_label>
    <other_name>Bupivacaine and sufentanil</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Sodium Chloride Injection</intervention_name>
    <description>Subcutaneous injection of Sodium chloride at the usual quadratum lumburum block 2 (QLB2) injection site under ultrasound (&quot;sham-QLB2&quot;).</description>
    <arm_group_label>Intrathecal morphine</arm_group_label>
    <other_name>sham-QLB2</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Morphine</intervention_name>
    <description>Morphine via pump (patient controlled analgesia)</description>
    <arm_group_label>Intrathecal morphine</arm_group_label>
    <arm_group_label>ropivacaine in quadratum lumburum block 2</arm_group_label>
    <other_name>injection of morphine</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patient to undergo a scheduled caesarean under spinal anesthesia, for the birth of a&#xD;
             term baby with a Pfannenstiel-type incision;&#xD;
&#xD;
          -  Patient in good health ;&#xD;
&#xD;
          -  Patient able to understand the information related to the study, read the information&#xD;
             leaflet and agree to sign the consent form.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Pregnancy less than 37 weeks with amenorrhea;&#xD;
&#xD;
          -  Multiple pregnancy;&#xD;
&#xD;
          -  Fetal pathology known at the time of inclusion;&#xD;
&#xD;
          -  Body mass index&gt; 45 kg / m²;&#xD;
&#xD;
          -  History of scoliosis or spine surgery;&#xD;
&#xD;
          -  History of chronic pain associated with taking opiates, neuropathic pain, neurological&#xD;
             pathology;&#xD;
&#xD;
          -  Preoperative anemia (blood hemoglobin &lt;9 g / dL);&#xD;
&#xD;
          -  Hypersensitivity to ropivacaine or other local anesthetics with amide bond;&#xD;
&#xD;
          -  Hypersensitivity to morphine or opioids;&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Olivier MAUPAIN, MD</last_name>
    <phone>06 77 37 24 78</phone>
    <email>omaupain@free.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>MAUPAIN</name>
      <address>
        <city>Quincy-sous-Sénart</city>
        <zip>91480</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Olivier MD MAUPAIN</last_name>
      <email>omaupain@free.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>February 8, 2021</study_first_submitted>
  <study_first_submitted_qc>February 12, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">February 16, 2021</study_first_posted>
  <last_update_submitted>September 14, 2021</last_update_submitted>
  <last_update_submitted_qc>September 14, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 16, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sufentanil</mesh_term>
    <mesh_term>Morphine</mesh_term>
    <mesh_term>Bupivacaine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

